Human CD137L Protein: Functions and Applications | Research Update

Unlock the potential of cancer immunotherapy with Human CD137L Protein from Alpha Lifetech Incorporation. Our cutting-edge product is designed to enhance anti-tumor immune responses and improve the efficacy of cancer treatment, Human CD137L Protein, also known as 4-1BBL, is a member of the tumor necrosis factor (TNF) ligand family and plays a crucial role in regulating immune responses. By engaging with its receptor CD137 on T cells, Human CD137L Protein can stimulate T cell proliferation and cytokine production, leading to robust anti-tumor immune responses, Our high-quality Human CD137L Protein is produced using advanced recombinant DNA technology, ensuring high purity and bioactivity. It can be used for in vitro studies to investigate immune responses and for the development of novel cancer immunotherapies, With our Human CD137L Protein, researchers and biopharmaceutical companies can accelerate their efforts in advancing cancer immunotherapy, ultimately leading to better treatment options for cancer patients. Join us in the fight against cancer and unleash the full potential of immunotherapy with Human CD137L Protein from Alpha Lifetech Incorporation